In 2023, the pain management devices market had a total size of USD 2,518.2 million, and it is projected to hit USD 4,792.2 million by 2030, advancing at a rate of 9.6%, during the projection period. 

The growth of the industry can be credited to the increasing occurrence of chronic conditions as lifestyle-associated illnesses, for instance, diabetes and obesity, drive the need for nerve and muscle stimulators. Other health problems that can result in pain are trauma or hypertension.

The key propeller for the pain management devices market is the growing count of individuals with chronic illnesses, numerous of whom have discomfort as the primary symptom. For example, high blood pressure significantly surges the danger of brain aneurysms, which, if broken, cause excruciating pain. As per the WHO’s data issued in March 2023, around 1.28 billion grownups aged 30 to 79 years have hypertension.

For Getting Sample Pages of This Report:-

https://www.psmarketresearch.com/market-analysis/pain-management-devices-market/report-sample

The growing number of amputation operations is also a major factor in the increasing requirement for pain management devices. A count of factors can result in amputations, like flesh-eating diseases, musculoskeletal conditions, vascular diseases, sports injuries, diabetes, violence (due to battles), and genetic factors. An amputation is mainly done when either the wound is too complex to be repaired and dangers harm to the surrounding tissue or to avoid the spread of illnesses, like gangrene, cancer, and necrotizing fasciitis.

Moreover, due to the high occurrence of neuropathic pain in the U.S., individuals are more reliant on pain management devices than drugs. According to an article in the journal Pain Medicine, about 2% of the individuals in the U.S. suffer from neuropathic pain. Therefore, as around half of the nation’s populace has at least one chronic disorder and supplementary pain, the industry continues to improve in the region.

Neurostimulation items had the largest income share in recent years, due to the surge in the occurrence of neurological illnesses. Neurostimulators play a vital role in the management of chronic pain because of Parkinson’s, apart from epilepsy, depression, and movement-related ailments. In this regard, the launch of progressive products and the rising ageing populace will drive the industry.